As indicated in these plots there was some variability regarding growth rates of mammary tumors in MTB-IGFIR/Akt1−/− and MTB-IGFIR/Akt2−/− mice, however, the majority of the tumors grew at a slower rate than the mammary tumors of MTB-IGFIR mice. This evidence concerns the gene AKT1 and breast cancer.